IL6 and depressive symptom measurement: We established that inflammatory cytokines, in particular IL-6 and IL-1β, as well as kynurenine pathway metabolites, are associated with the severity of depressive symptoms in pregnancy and the postpartum, and that these markers were useful to predict the future development of depression during pregnancy.